mplus_toric

Premium: LENTIS Mplus (X)toric intraocular lenses

The best combination of two high-tech solutions: with the multifocal-toric LENTIS Mplus Xtoric and Mplus Toric, the innovative presbyopia correction of the advanced LENTIS Mplus Family and the optimal astigmatism treatment of the new LENTIS Tplus X were combined. The result: optimal vision for your patients!

Category: .

LENTIS Mplus (X)toric intraocular lenses

Lentis Mplus Xtoric Header Button
Extend your Vision!

The best combination of two high-tech solutions: with the multifocal-toric LENTIS Mplus Xtoric and Mplus Toric, the innovative presbyopia correction of the advanced LENTIS Mplus Family and the optimal astigmatism treatment of the new LENTIS Tplus X were combined. The result: optimal vision for your patients!

Toric functionality with simplified implantation characteristics

With the toric Mplus-IOLs we offer a personalised solution for patients suffering from presbyopia in combination with regular corneal astigmatism. Due to its specially-designed optics, the toric MIOL compensates for all forms of corneal irregularities, thus providing sharp and clear vision.

In addition, the preset inferior placement of the multifocal near segment and the accordingly adjusted torus facilitate the orientation and thus the implantation. The proven plate-haptic design guarantees optimum rotational stability.

Lentis Mplus Xtoric Implantation
Simplified operation: The preset inferior placement of the multifocal near segment and the individually adjusted torus simplify orientation and implantation.
The toric IOL of the LENTIS Mplus Family offer many advantages compared with
common rotationally symmetric multifocal-toric IOL
LENTIS Mplus Family - attributes
  • Excellent visual acuity results for the near, intermediate and distance ranges
  • Extended depth of focus and optimised image quality for all ranges of vision
  • Increased pupil independence, now suitable for very small pupils
  • Minimal halo and glare effects
  • Maximised light efficiency of > 95%
  • +1.5D, +2.0D and +3.0D addition
LENTIS Tplus X - attributes
  • Individual and highly accurate astigmatism correction to precisely 0.01D
  • Natural high contrast and colour perception
  • True 360° sharp optic edge for best-possible PCO prevention
  • Very high rotational stability thanks to its haptic design
  • Optional: Violet light filter for improved retinal protection
Toric LENTIS IOL for an eXact astigmatic correction!
In a large-scale clinical trial, conducted by Professor Jan Venter (MD, Optical Express, London), multifocal toric intraocular lenses of the LENTIS Mplus Toric type were implanted in 1,030 eyes. The lenses are tailored to each patient’s parameters with an accuracy of 0.01 diopters and the outcomes proved convincing owing to their excellent refractive results, the precise correction of astigmatism and presbyopia, and above-average patient satisfaction.
Lentis Mplus Toric astimatism correction
Clinical study

Prof. Dr. Magda Rau, Ocni Centre Prag, Privat Clinic Dr. Rau, Augenklinik Cham

In a recent clinical study, led by Prof. Dr. Magda Rau, 10 multifocal toric LENTIS Mplus Xtoric intraocular lenses were examined with respect to their optical performance. The study confirms very good functional results with a very high patient satisfaction and a maximum spectacles independence post-OP for this advanced IOL. The toric MIOL was bilaterally implanted without complications and distinguished itself by the prescribed inferior placement of the multifocal near segment and the correspondingly adjusted torus. These factors simplify the alignment and therefore lead to a simplified implantation behavior.

Lentis Mplus Xtoric Study
LENTIS Mplus Xtoric and Mplus Toric with violet light filter

HydroSmart Protect is an innovative acrylate with optimized filtering properties enhances contrast sensitivity and provides a natural color vision. LENTIS intraocular lenses feature a unique violet light filter without affecting the transmission of blue light.

All advantages and benefits for you and your patients at a glance:

  • Optimises filtering properties thanks to a high-quality violet light filter
  • Enhances scotopic contrast, color sensitivity and night vision
  • Minimises loss of light by reduced inherent coloration of the filter
  • Efficient combination of hydrophilic material and a hydrophobic surface
  • Improves biocompatibility by using a well-tolerated material in combination
    with a unique production technology
  • Its enhanced flexibility makes this material suitable for MICS and mini-incision surgery

While many open questions about a possible relationship of AMD progression and blue light blocking filters still await final clarification, it has been demonstrated that violet light blocking lenses have the same photoprotective effect as blue filtering lenses. However, they provide both higher scotopic sensitivity and enhanced melanopsin sensitivity than the so-called blue light blockers!

Melanopsin may have a crucial influence on the circadian rhythm and its positive effects on human physiology.

Reference list (Violet light filter):

Steinert, R. et al., Healthy Blue Light and the Eye, Supplement to Cataract & Refractive Surgery Today, March 2008

Lane, N., To block or not to block – is blue light the enemy? Eurotimes 2007

Mainster, M., Turner, P., Blue Light: To Block or Not To Block, Cataract & Refractive Surgery Today Europe, May 2007

Mainster, M., Violet and blue light blocking intraocular lenses: photoprotection versus photoreception, British Journal of Ophthalmology 2006; 90; Page 784–792

Transmissionskurve HydroSmart Protect
What do the professionals say about the LENTIS Mplus Xtoric?
“The Mplus Xtoric IOL provides good visual acuity for all ranges of vision. In comparison with the first-generation LENTIS Mplus IOL, the near visual acuity has improved with the Mplus Xtoric, and my patients no longer require spectacles for reading small print or computer use. Additionally, because of the reduction in the incidence of glare and halos with the Mplus Xtoric IOL in comparison to some rotationally symmetric multifocal IOLs I have pre­viously implanted, I am able to implant the Mplus Xtoric lens also in my demanding male patients. The improve­ment in near visual acuity that this lens provides makes it a great choice for my female patients as well. As a result, I am now able to offer one lens—the LENTIS Mplus Xtoric IOL—to all of my patients, regardless of gender.”

Magda Rau, MD, is the Head of the Augenklinik Cham and Refractive Privatklinik- Dr. Rau, Cham, Germany, and Eye Centre Prag, Czech Republic and a Visiting Professor at the Bulgarian-American Eye Institute ProLight, 02/2014.

“The new IOL design seems to improve intermediate vision and minimize the incidence of halos and glare, especially with large pupils in younger patients. As another important point, the near segment works well in eyes with small pupils, which is common in cataract patients. Patients already had no major complaints with the LENTIS Mplus, but with the new Mplus X lens design, patient satisfaction seems to be even higher. The LENTIS Mplus Xtoric is a great tool for our presbyopic patients to achieve spectacle independence.“

Ruediger Schmid, FEBO, practices at the AugenAllianz Zentren Dillingen, Germany, 02/2014.

What do the professionals say about the LENTIS Mplus Toric?
“I have to say that, of all the multifocal toric IOLs on the market, the best experience we have had, has been with the Mplus Toric. The loss of light is the lowest among all of the multifocal lenses, and the accuracy of the IOL manufacturing is excellent. Another good thing about the Mplus Toric is that the lens is always implanted in the same position; there is no need to rotate the lens toward the axis of astigmatism. You just implant it at the 12- o’clock position (90º), and it always fits well in the eye. I have yet to see a case in which the lens decenters, and this is much more than I can say for competing lenses from other companies.”

Gerd U. Auffarth, MD, PhD in LENTIS Mplus and LENTIS Mplus Toric – Advanced multifocal IOL technology for the treatment of presbyopia, astigmatism, and cataract, supplement to CRST Europe 02/2012.

“We started implanting the Mplus in October 2010. To date, we have implanted this lens in more than 2,000 eyes. We then started with the Mplus Toric in February 2011 and have already implanted this lens in approximately 350 eyes. The main feeling across our centers is that the Mplus and the Mplus Toric are really good lenses. We have no buts anymore; there simply are not the side effects we have seen with other multifocal IOLs.“

Anders Granberg, MD, PhD in LENTIS Mplus and LENTIS Mplus Toric – Advanced multifocal IOL technology for the treatment of presbyopia, astigmatism, and cataract, supplement to CRST Europe 02/2012.

„We have been implanting the LENTIS Mplus Toric since November 2010 and so far our experience has been very good. This is partly because we only implant the ‘customised’ version. In practical use and with regard to implantation behaviour, this toric MIOL clearly showed excellent results in terms of the good visibility of the position of the cylinder axis and the resulting simplified implantation, plus the positioning charts also supplied for the operating theatre monitor.“

Lutz Bauer, MD, PhD in LENTIS Mplus Toric – Erfahrungsbericht aus der Praxis, Oculentis NEWS 02/2011.

Bibliography:Detlev R. H. Breyer, MD, Successful Implantation of Toric Multifocal IOLs – Respecting patients‘ visual demands and applying precise preoperative diagnostics are key, Cataract & Refractive Surgery Today Europe 06/2014.Robert Morris, MD, Evaluating a toric lens with low add power, Ophthalmology Times, 04/2014Reference: Robert Morris, MD, Clinical performance of a multifocal toric intraocular lens with rotationally asymmetric design and +1.50 addition, free paper presentation, ESCRS 2013, Amsterdam, The NetherlandsSunil Shah, MD, FRCOphth, FRCS(Ed), Magda Rau, MD, Detlef Holland, MD, Julian D. Stevens, MRCP, FRCS, FRCOphth, Gerd U. Auffarth, MD, PhD, FEBOphth, Florian T.A. Kretz, MD, FEBO, Manfred R. Tetz, MD, Detlev R.H. Breyer, Hiroyuki Arai, MD, PhD, Ludger Hanneken, MD, Dominique Pietrini, MD, Ruediger Schmid, MD, FEBO, Ben Wanders (CEO Oculentis BV), Experts Uncover the neXt generation of LENTIS IOLs – Innovative solutions for presbyopia, laser refractive cataract surgery IOLs, AMD, and more, Supplement to Cataract & Refractive Surgery Today Europe 02/2014

Magda Rau, MD, The new improved Lentis Mplus Toric: The first results, 2nd International Oculentis User Meeting, Appledorn, 09/2013.

Jan A. Venter, MD, Martina Pelouskova, MSc, Barrie M. Collins, Dip.Optom (SA), PhD,Steven C. Schallhorn, MD, Stephen J. Hannan, MCOptom, Visual outcomes and patient satisfaction in 9366 eyes using a refractive segmented multifocal intraocular lens, Journal of Cataract & Refractive Surgery, 2013; 2013 ASCRS and ESCRS.

Jan A. Venter, MD, Martina Pelouskova, MSc, Outcomes and complications of a multifocal toric intraocular lens with a surface-embedded near section, Journal of Cataract & Refractive Surgery, Volume 39, Issue 6, June 2013.

Gerd U. Auffarth, MD, PhD, FEBOphth, Detlev R.H. Breyer, MD, Erik L. Mertens, MD, FEBOphth, Jaime Aramberri, MD, Edmondo Borasio, MedCBQ, Claudio Carbonara, MD, Anders Granberg, MD, Johnny Moore, MD, PhD, Dominique Pietrini, MD, Jan A. Venter, MD, LENTIS Mplus and LENTIS Mplus Toric – Advanced multifocal IOL technology for the treatment of presbyopia, astigmatism, and cataract, European expert roundtable SUPPLEMENT TO CATARACT & REFRACTIVE SURGERY TODAY EUROPE I 01/2012.

Gerd U. Auffarth, MD, PhD, FEBOphth, Optical side-effects of presbyopia-correcting IOLs and corneal procedures, presentation at the Joint Congress of SOE & AAO, 4.-7. June 2011, Geneva.

Gerd U. Auffarth, MD, PhD, FEBOphth, Jorge L. Alio, MD, PhD, Erik L. Mertens, MD, FEBOphth, Ruth Lapid-Gortzak, MD, Manfred R. Tetz, MD, PhD, Sunil Shah, MD, FRCOphth, FRCS(Ed) LENTIS Mplus – The only presbyopia lens with HD-Vision, European expert roundtable, SUPPLEMENT TO CATARACT & REFRACTIVE SURGERY TODAY EUROPE I 05/2010.

Gerd U. Auffarth, MD, PhD, FEBOphth et al, Oculentis LENTIS Mplus: An innovative multifocal intraocular lens technology. Cataract & Refractive Surgery Today Europe. 02/2010, 34-35.

P. J. Pisella, MD, University Ophthalmology Clinic François-Rabelais/Bretonneau, Tours, France, Data on File.

Sunil Shah, MD, FRCOphth, FRCS(Ed), Buckhurst PJ, Wolffsohn JS, Naroo SA, Davies LN, Bhogal GK, Kipioti A, Assessment of visual function using defocus curves, Ophthalmic Research Group, School of Life and Health Sciences, Aston University, Birmingham, United Kingdom, 2013, data on file.

Sunil Shah, MD, FRCOphth, FRCS(Ed), Management of Mplus Problems, Midland Eye Institute, 2013, Data on File.

Sunil Shah, MD, FRCOphth, FRCS(Ed), Buckhurst PJ, Wolffsohn JS, Naroo SA, Davies LN, Bhogal GK, Kipioti A, Multifocal intraocular lens differentiation using defocus curves, Invest Ophthalmology Vis Sci. June 2012 22;53(7):3920-6.

Lentis Header Button

LENTIS: Large selection of IOL designs

Oculentis offers a variety of IOL designs. Choose between (a)spherical, 1-piece or 3-piece IOL, IOL with or without violet light filtering technology
Aspherical intraocular lenses

The imaging quality of intraocular lenses (IOL) is one of the key factors to ensure an optimal vision for patients after a cataract surgery.

Aspherical LENTIS IOL are characterized by an aberration corrective surface structure. Basis for their design is not as usual a purely spherical cornea but a slightly aspherical cornea (anticipated in the human eye). Studies have shown that the human cornea shows asphericity in respect of the statistical median. Due to this fact, Intraocular lenses, which take into account this aberration, lead to a better visual acuity and better image quality.

Lentis lenses
Figure: All aspherical LENTIS lenses are also available with violet light filter: LS-312Y and LS-313Y
 
Lentis lenses

LS-412Y:

Oculentis’ 3-piece aspheric IOL with violet light filter is by its overall diameter of 13.0 mm (optical diameter 6.0 mm) the perfect intraocular lens for the optimal sulcus fixation.

 

 

SML-Technology
All aspherical LENTIS lenses are manufactured in the sub-micron lathing process. The square-edge design and the superior surface quality of our HydroSmart Acrylic reduce the post-surgery-cataract formation and thus the post-treatment rate. A recent study conducted by the Berlin Eye Research Institute (BERI confirms the exceptionally sharp optic edges of the LENTIS IOL for a better PCO prophylaxis (Study as PDF-Download below). All LENTIS lenses show an excellent biocompatibility and high stability in the capsule bag.

 

Spherical intraocular lenses
All spherical lenses of Oculentis are manufactured with a state-of-the-art Sub-Micron Lathing technique. Thanks to this technology, the lenses do not require additional polishing after production and thus keep their square edges. This “square edge design“ as well as the excellent surface quality lead to a lower rate of secondary cataract formation and thus reduce the need for additional treatment.
Lentis lenses
Figure: All spherical LENTIS lenses are also available with violet light filter.
For more detailed specification regarding our LENTIS IOL refer to the respective product information or contact our Team International Representative

Excursus about Asphericity

Spherical Intraocular Lenses

Spherical aberrations are an optical imaging error, which leads to impaired vision. External light rays are refracted more strongly than the more central rays (see figure). Therefore, not all light rays will focus on the macula (yellow spot or „point of sharpest vision“). This results in poor contrast sensitivity. Spherical intraocular lenses do not correct these aberrations.

Spheric

Aspherical LENTIS Intraocular Lenses

All aspherical LENTIS intraocular lenses correct these spherical aberrations. The aspherical lens surface focuses all the light rays correctly on the macula. Thereby an optimal image on the retina is created which leads to a very good contrast sensitivity for the patient. In turn twilight vision will be improved.

Aspheric
OCULENTIS FAQ:

oculentis-faq1

oculentis-faq2

oculentis-faq3

oculentis-faq4
oculentis-faq5